Personalis, Inc. (PSNL) Shareholder Equity
- 2026-06-30: Additional Paid in Capital, Common StockUSD $928.24M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-118.00K; Retained Earnings (Accumulated Deficit)USD $-692.98M; Stockholders' Equity Attributable to ParentUSD $235.16M.
- 2026-03-31: Additional Paid in Capital, Common StockUSD $916.12M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-70.00K; Retained Earnings (Accumulated Deficit)USD $-661.29M; Stockholders' Equity Attributable to ParentUSD $254.76M.
- 2025-12-31: Additional Paid in Capital, Common StockUSD $892.33M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $104.00K; Retained Earnings (Accumulated Deficit)USD $-631.26M; Stockholders' Equity Attributable to ParentUSD $261.19M.
- 2025-09-30: Additional Paid in Capital, Common StockUSD $778.77M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $82.00K; Retained Earnings (Accumulated Deficit)USD $-607.45M; Stockholders' Equity Attributable to ParentUSD $171.41M.
Personalis, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Common Stock, Value, Outstanding USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $928.24M | $-118.00K | $-692.98M | $235.16M | $10.00K | 3 month · $3.98M 6 month · $6.53M | (m) | (m) |
| 2026-03-31 | $916.12M | $-70.00K | $-661.29M | $254.76M | $10.00K | 3 month · $2.55M | (m) | (m) |
| 2025-12-31 | $892.33M | $104.00K | $-631.26M | $261.19M | $10.00K | 12 month · $9.43M | (m) | (m) |
| 2025-09-30 | $778.77M | $82.00K | $-607.45M | $171.41M | $9.00K | 3 month · $2.08M 9 month · $7.13M | (m) | (m) |
| 2025-06-30 | $776.60M | $20.00K | $-585.80M | $190.83M | $9.00K | 3 month · $2.83M 6 month · $5.05M | (m) | (m) |
| 2025-03-31 | $773.09M | $-18.00K | $-565.74M | $207.34M | $9.00K | 3 month · $2.22M | (m) | (m) |
| 2024-12-31 | $752.96M | $-23.00K | $-549.99M | $202.96M | $9.00K | 12 month · $10.69M | (m) | (m) |
| 2024-09-30 | $700.23M | $87.00K | $-533.57M | $166.76M | $7.00K | 3 month · $2.68M 9 month · $8.02M | (m) | (m) |
| 2024-06-30 | $606.86M | $-120.00K | $-494.48M | $112.27M | $5.00K | 3 month · $2.65M 6 month · $5.34M | (m) | (m) |
| 2024-03-31 | $602.49M | $-125.00K | $-481.67M | $120.69M | $5.00K | 3 month · $2.69M | (m) | (m) |
| 2023-12-31 | $598.36M | $-222.00K | $-468.71M | $129.44M | $5.00K | 12 month · $14.05M | (m) | (m) |
| 2023-09-30 | $593.62M | $-302.00K | $-442.12M | $151.21M | $5.00K | 3 month · $3.48M 9 month · $10.66M | (m) | (m) |
| 2023-06-30 | $589.42M | $-313.00K | $-413.02M | $176.09M | $5.00K | 3 month · $3.48M 6 month · $7.18M | (m) | (m) |
| 2023-03-31 | $583.15M | $-455.00K | $-389.07M | $193.63M | $5.00K | 3 month · $3.69M | (m) | (m) |
| 2022-12-31 | $579.46M | $-912.00K | $-360.41M | $218.14M | $5.00K | 12 month · $19.43M | (m) | (m) |
| 2022-09-30 | $573.16M | $-1.42M | $-329.34M | $242.40M | $5.00K | 3 month · $4.42M 9 month · $13.65M | (m) | (m) |
| 2022-06-30 | $568.74M | $-1.26M | $-302.85M | $264.63M | $5.00K | 3 month · $4.42M 6 month · $9.23M | (m) | (m) |
| 2022-03-31 | $562.89M | $-875.00K | $-275.30M | $286.71M | $5.00K | 3 month · $4.82M | (m) | (m) |
| 2021-12-31 | $557.56M | $-166.00K | $-247.09M | $310.30M | $4.00K | 12 month · $14.38M | (m) | (m) |
| 2021-09-30 | $552.18M | $12.00K | $-226.90M | $325.30M | $4.00K | 3 month · $3.69M 9 month · $10.35M | (m) | (m) |
| 2021-06-30 | $547.95M | $18.00K | $-209.23M | $338.75M | $4.00K | 3 month · $3.60M 6 month · $6.66M | (m) | (m) |
| 2021-03-31 | $542.69M | $-5.00K | $-194.27M | $348.42M | $4.00K | 3 month · $3.06M | (m) | (m) |
| 2020-12-31 | $376.79M | $22.00K | $-181.87M | $194.94M | $4.00K | 12 month · $8.24M | (m) | (m) |
| 2020-09-30 | $372.03M | $37.00K | $-168.53M | $203.54M | $4.00K | 3 month · $1.69M 9 month · $4.76M | (m) | (m) |
| 2020-06-30 | $252.00M | $106.00K | $-158.98M | $93.12M | $3.00K | 3 month · $1.82M 6 month · $3.07M | (m) | (m) |
| 2020-03-31 | $248.85M | $73.00K | $-149.73M | $99.20M | $3.00K | 3 month · $1.25M | (m) | (m) |
| 2019-12-31 | $247.28M | $-6.00K | $-140.59M | $106.69M | $3.00K | 12 month · $4.86M | (m) | (m) |
| 2019-09-30 | $245.36M | $-29.00K | $-133.94M | $111.39M | $3.00K | 3 month · $1.40M 9 month · $3.66M | (m) | 3 month · $197.00K |
| 2019-06-30 | $244.09M | $-15.00K | $-127.06M | $117.02M | $3.00K | 3 month · $1.65M 6 month · $2.25M | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | $-110.52M | (m) | 3 month · $609.00K | (m) | (m) |
| 2018-12-31 | $9.13M | $-15.00K | $-115.50M | $-106.39M | $1.00K | 12 month · $1.32M | 12 month · $4.69M | (m) |
| 2018-09-30 | (m) | (m) | (m) | $-103.29M | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | $-100.80M | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | $-92.60M | (m) | 12 month · $753.00K | (m) | (m) |
| 2016-12-31 | (m) | (m) | (m) | $-69.84M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |